The mammalian brain relies primarily on glucose as a fuel to meet its high metabolic demand. Among the various techniques used to study cerebral metabolism, 13 C magnetic resonance spectroscopy (MRS) allows following the fate of 13 C-enriched substrates through metabolic pathways. We herein demonstrate that it is possible to measure cerebral glucose metabolism in vivo with sub-second time resolution using hyperpolarized 13 C MRS. In particular, the dynamic 13 C-labeling of pyruvate and lactate formed from 13 C-glucose was observed in real time. 
Dynamic in vivo 13 C MRS combined with the injection of 13 C-enriched substrates is a powerful method for studying cerebral intermediary metabolism 1 . It is well established that, although the energy requirement of the brain can be satisfied by the oxidation of other substrates such as ketone bodies, lactate and fatty acids, glucose is the main cerebral metabolic fuel 2 . The improved sensitivity and resolution of high-magnetic field 13 C MRS has increased the reliability of 13 C-enrichment time evolution measurements so that metabolic fluxes can now be determined accurately. The temporal resolution currently achievable in the rodent brain upon infusion of [1, [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-D-glucose is around 5 min for detection of 13 C labeling in the aliphatic carbons of glutamate, glutamine and aspartate, and about 20 min for detection of less concentrated metabolites such as γ-aminobutyrate, alanine and lactate 3 . Other important intermediary metabolites present in low concentration such as pyruvate can simply not be detected in the rodent brain by conventional thermally polarized 13 C MRS. Over the past few decades, multiple technological advances have been implemented to overcome the inherent low sensitivity of nuclear magnetic resonance (NMR) and MRS 4 . This lack of sensitivity comes from the fact that the NMR/MRS signal is directly proportional to the nuclear spin polarization P n defined as the relative difference between the populations of the different nuclear spin quantum states. This polarization is inherently small at room or body temperature even in a magnetic field as high as 9.4T where P n < 8 × 10 −6 for 13 C spins at 37 °C. To enable detection of less concentrated metabolites in vivo, a tremendous 13 C signal enhancement in the biomolecules of interest can be achieved using so-called "hyperpolarization" techniques. The development of hyperpolarization, in particular dissolution dynamic nuclear polarization (DNP) which can increase the room-temperature 13 C polarization of molecules in solution by several orders of magnitude 5 , leads to the possibility of following uptake and metabolism in vivo in real time 6 . To obtain large polarization enhancements by DNP, it is necessary to prepare frozen glassy solutions containing a labeled substrate at high concentration and a few tens of mM of suitable paramagnetic centers as polarizing agents. The frozen samples are placed in a polarizer, an instrument operating at moderately large magnetic field (~3-7 T) and low temperature (~1 K).
To date, only a restricted number of hyperpolarized 13 C MRS brain studies have been performed 7 , mostly using pyruvate as substrate. Three metabolic products, lactate, alanine and bicarbonate 8, 9 , were observed following the injection of [ 16 . While the C 1 lactate signal was clearly observable as a doublet, these data also highlighted the major drawback of perdeuterated [U- 13 C 6 ]-D-glucose as a hyperpolarized glycolytic probe: the splitting of the lactate signal on top of the short 13 C T 1 further lowers the signal-to-noise (SNR) ratio. In this particular article, it was suggested that developing a 3-, 4-, or 3,4-13 C-labeled perdeuterated glucose would lengthen the longitudinal relaxation time of the 13 C nuclei by eliminating the 13 C-13 C homonuclear dipolar relaxation 16 . In addition, this labeling strategy will also metabolize to singly [1- 13 C]-labeled lactate, improving the detection limits of lactate. The aim of the present study was to show that cerebral glucose metabolism can be measured in vivo using hyperpolarized 13 C MRS. We demonstrated that several metabolites can be detected in the healthy mouse brain following the i.v. injection of hyperpolarized 13 C-glucose. We also developed a convenient synthesis to produce [2,3, [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-D-glucose starting material, our goal was to develop a simple, high yield route to prepare deuterated glucose. The established methods for the deuteration of carbohydrates rely on the replacement of covalently bound hydrogens with deuterium using D 2 O and a transition metal catalyst such as Raney Ni or Ru/C [17] [18] [19] [20] [21] . After careful consideration of the literature data and some preliminary experimentation, we adopted the Ru/C method largely because the deuterated Raney Ni catalyst required long reaction times, which lead to significant isomerizations and formation of other side products 19, 22 . The synthesis of [2,3,4,6,6- . Consequently, we first converted [3, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C 2 ]-D-glucose to the methyl glucoside (1) under standard conditions by stirring the compound in sulfuric acid in methanol at reflux overnight. The resulting methyl glucoside was then dissolved in D 2 O, the Ru/C catalyst was added, and the reaction mixture was stirred under an atmosphere of hydrogen at 80 °C. This resulted in incomplete deuteration largely at the C3 position. Simple removal of the used Ru/C by filtration and adding fresh catalyst proved to be an efficient way of increasing the deuteration. This iteration was repeated until the desired percent deuteration was achieved (>95% deuteration required three repetitions). The final step of the synthesis was the hydrolysis of the glycosidic bond by refluxing the deuterated product in 1 M HCl. The overall yield of the desired final product was about 75% starting from [3,4- C polarization in the latter compound was measured to be 13% (see ref. 23 , Tables S1 and S2, as well as Fig. S1 ). The liquid-state T 1 values for both compounds were measured at 9.4T and room temperature after dissolution with water or D 2 O. These T 1 s were determined from the fitting of the hyperpolarized magnetization decay curves. As seen from the values displayed in Table 1 , the apparent T 1 s of the 3,4-13 C 2 -labeled and the uniformly labeled derivatives do not differ significantly. Deuteration of the solvent increased the T 1 s by approximately 20%, in agreement with previously reported results in which it was shown that dipole-dipole relaxation is the major relaxation mechanism for 13 C spins in carbohydrates 24 . The liquid-state polarization of hyperpolarized [U-2 H 7 , U-13 C 6 ]-D-glucose was measured inside a custom-designed injection pump following DNP at 7T/1K, dissolution in D 2 O and transfer into the bore of a 9.4T MR scanner, using a previously described method 25, 26 . The polarization was determined by comparing the hyperpolarized 13 C-glucose signal and its corresponding thermally polarized signal (see example in Fig. S2 ). The average 13 C polarization values are presented in Table 2 . These correspond to the polarization levels at the time of the animal intravenous (i.v.) injection.
In vivo

C MRS.
To optimize signal-to-noise ratio (SNR) of the expected glucose metabolites in the carboxyl region of the 13 C spectra, in particular [1-13 C] lactate and [1-13 C] pyruvate, we applied an RF excitation pulse designed to excite the glucose resonances by a minute flip angle, while exciting the region of interest with a large flip angle (20°) (See Fig. 2A and B). The latter was determined using the following considerations: taking into account the published in vivo 13 C T 1 of perdeuterated [U- 13 C 6 ] glucose of 9 s 16 , the maximum SNR that can be obtained after summing all spectra recorded with an achievable repetition time (greater or equal to 500 ms) corresponds to a flip angle of 20° (see Fig. 8 in ref. 27 ). This strategy allowed following build-up of glucose metabolites for more than 30 s.
Subsequent to the injection of perdeuterated [U- 13 C 6 ]-D-glucose, the formation of a doublet peak assigned to the lactate resonance could be readily detected at 183.5 ppm with 50 Hz 13 C- 13 C coupling (Fig. 3) . In the summed spectrum, two additional doublet peaks were detected: one centered at 171.1 ppm with 43 Hz 13 C- 13 C coupling corresponding to the pyruvate C1 resonance and an additional peak centered at Table 2 . Liquid-state polarization measured inside the infusion pump (n = 3). (Fig. 4) . When using [2,3,4,6,6-2 H 5 , 3,4-13 C 2 ]-D-glucose, the doublet peaks detected at the same frequencies of the three glucose metabolites were coalesce into single peaks due to the lack of the 13 C-13 C coupling. The peak at 179.8 ppm could then be tentatively assigned to [1- 13 C] 3PG, (see Fig. 4 ). The high impurity content of the 
Discussion
This study reports for the first time that 13 C-lactate and 13 C-pyruvate signals can be detected in the mouse brain as rapidly as 10 s following an i.v. injection of hyperpolarized 13 C-glucose despite its relatively short longitudinal relaxation time. The lactate-to-pyruvate ratio is in agreement with earlier measurements in the mouse brain 28, 29 indicating that after the 50.5 s elapsed from the injection, metabolism had reached steady-state. The blood glucose concentration did not exceed the typical values used in glucose tolerance tests 30 , with a maximum blood concentration of 17 ± 3 mM following injection. The experimental protocol designed for this study includes optimization of sample formulation, combined with rapid dissolution and transfer and efficient MRS acquisition scheme enabled to dynamically measure lactate formation in the brain in real time during 30 s. The excellent SNR of the experiment provides the opportunity to quantify the signal intensities and to define the time evolution of the lactate formation. This kind of data could then be used for modeling to obtain metabolic rates and as an alternative to directly quantify CMRglc by MRS 31 . An ad-hoc chemical synthesis designed to deuterate and specifically 13 C-label the glucose carbons 3 and 4 was developed for this study. These correspond to the two 13 C nuclei labeling the carboxyl group of pyruvate and lactate and they have the longest 13 C T 1 in those metabolites. The similar T 1 values of the 3,4-13 C 2 -labeled and the uniformly labeled derivatives indicates that 13 C homonuclear coupling is not a major source of relaxation. Moreover, this synthesis is general and could be used to deuterate any specifically 13 C-label glucose that could potentially be used as hyperpolarized metabolic probes.
Using specifically 13 C-labeled glucose, transfer of the 13 C-enriched carbon from glucose to lactate is less ambiguous and is not influenced by potential confounding pathways such as the pentose phosphate pathway or scrambling of carbons through the various transketolase and transaldolase enzymes. In our case using hyperpolarized [2,3,4,6,6-2 H 5 , 3,4-13 C 2 ]-D-glucose and with the detection at the carboxyl carbon resonances (160-190 ppm), there is less ambiguity in the peak assignment of the resonance at 179.8 ppm which we have tentatively identified as the glycolytic intermediate 3PG. Further investigations will be necessary to confirm this assignment. Additionally, it led to a substantial improvement in the 13 C MRS SNR mainly due to the absence of 13 C-13 C splitting in the detected metabolic products of [2,3,4,6,6- 2 H 5 , 3,4-13 C]-D-glucose. It is nevertheless important to mention that perdeuterated [U- 13 C 6 ]-D-glucose has also allowed us to determine the lactate-to-pyruvate ratio and to monitor the build-up of lactate, so specific 13 C labeling of glucose is not mandatory for all in vivo studies. Our findings demonstrate that hyperpolarized 13 C-glucose might provide complementary kinetic data when compared to 18 F-FDG PET that provides information on glucose phosphorylation and has been shown to behave differently from glucose shortly after injection 32 . Abnormal glucose metabolism is indeed implicated in several diseases, including neurodegenerative diseases 33 , and the application of the method reported here, perhaps also in combination with thermally-polarized 13 C-labeled glucose should prove useful in metabolic studies in various animal models. Note that for quantitatively assessing real-time glucose cerebral utilization, it may be necessary to use a different anesthetic since isoflurane is well known to affect cerebral metabolism 34, 35 .
Methods
Glucose synthesis. [3,4- 49 mmol) was dissolved in dry methanol (300 mL). Concentrated sulfuric acid (0.500 mL) was added and the solution was stirred at reflux (~80 °C bath temperature) overnight. Upon completion and to avoid side reactions due to the presence of concentrated sulfuric acid, the reaction mixture was treated with freshly prepared Dowex (1 × 4) anion exchange resin in the hydroxide form to remove excess acid. The beads were then filtered and washed with water. The reaction mixture was concentrated by rotary evaporation. The resulting pale-yellow syrup was impregnated with silica gel and subjected to flash chromatography with dichloromethane containing increasing amount of methanol (7.5% to 15%). The fractions containing the product were combined and evaporated to give a clear syrup (1.00 g, 93% yield). The product was a mixture of the α (60%) and the β (40%) anomers as indicated by the NMR data. solved in deuterium oxide (~20 mL). 10 mol % ruthenium on carbon (Ru/C) was added to the solution. The reaction vessel was purged with hydrogen gas and equipped with a hydrogen filled balloon. The reaction was heated to 80 °C (bath temperature) and stirred for 24 hours. The reaction mixture was filtered through a Celite S plug and washed with copious amounts of methanol. The filtrate was concentrated by rotary evaporation. If NMR indicated insufficient deuteration, the hydrogen-deuterium exchange reaction was repeated on the crude pale-yellow syrup filtrate. Upon verification of sufficient deuterium incorporation, the pale-yellow syrup was impregnated on silica gel and subjected to flash chromatography with dichloromethane containing increasing amount of methanol (5% to 15%). The fractions containing the product gave a clear syrup (857 mg, 93% yield). The product was a mixture of the α (65%) and the β (35%) anomers as indicated by the NMR data. Dynamic nuclear polarization at 7T/1K. The samples designed for in vivo experiments were all polarized at 7 T and and 1 ± 0.05 K using a custom-designed DNP polarizer described in earlier publications 25, 36 . The microwave power at the output of the source was set to 50 mW and the irradiation frequency was set to 196.8 GHz. The nuclear polarization was monitored as a function of time by means of pulsed NMR using 5-degree tipping pulses. Following DNP polarization, the hyperpolarized 13 C-glucose solutions were rapidly dissolved and transferred into an infusion pump placed inside the bore of a 9.4 T imager, with a delay between dissolution and infusion set to 3 s 37 . The pump was programmed to automatically inject 500 µL of the hyperpolarized solution (glucose concentration ~100 mM) into a mouse femoral vein.
Animal preparation. All experimental procedures involving mice were approved by the regulatory body of the Canton Vaud, Switzerland (Service de la consommation et des affaires vétérinaires) and all experiments were conducted according to Federal and local ethical guidelines. Animals were housed in a 12 h light/dark cycle, with ad libitum access to food and water and were fasted 12 h prior to the hyperpolarized 13 C-glucose injection. The glucose blood level before injection were within normal physiological concentrations 30 (4.7 ± 1 mM). In vivo experiments were performed on C57BL/6 J female mice (20.5 ± 1.5 g). Animals were anesthetized with 1.5% isoflurane in a 30% O 2 /70% N 2 O mixture and a femoral vein was catheterized for glucose injection. The mouse was placed on a holder along with the infusion pump and the femoral vein catheter was connected to the outlet of the pump. The holder was then inserted inside the scanner. A bolus of 500 µl of hyperpolarized solution at 100 mM 13 C-glucose concentration was injected within 9 s. The sample contained ~100 µM trityl radical. Mouse physiology was monitored and body temperature was maintained throughout the experiment (body temperature between 37-38 °C and respiration rate at 100 min −1 by adjustment of the isoflurane dose). All animals were kept under anesthesia for a maximum time of 2 h. Glucose blood levels were measured from the tip of the tail before the holder was inserted inside the scanner and immediately after the completion of the data acquisition. The animals were euthanized at the end of each experiment with an overdose of pentobarbital.
In vivo
13 C MRS measurements. Measurements were carried out on a Varian INOVA spectrometer (Varian, Palo Alto, CA, USA) interfaced to a 31-cm horizontal-bore actively-shielded 9.4T magnet (Magnex Scientific, Abingdon, UK). RF transmission and reception were performed with a custom-designed hybrid probe consisting of a proton quadrature surface coil and a three-loop 10-mm diameter carbon surface coil placed on the top of the mouse head. High order shimming was performed using the FASTESTMAP protocol 38 . RF excitation was performed using 20° selective Gaussian pulses (250 μs/40 kHz bandwidth) centered at 183.5 ppm and applied every 500 ms, with effective tilt angle of 1.4° at 95 ppm and −0.05 at 73 ppm. The acquisition time was set to 200 ms with a spectral bandwidth of 30 kHz. Data was processed using JMRUI
